Irritable bowel syndrome (IBS) supports the concept of a dysregulated hypothalamic—pituitary—adrenal (HPA) axis. This study investigates the neuroendocrine and psychological responses to the acute physical stress of a lumbar puncture (LP) in women with diarrhea-predominant IBS by assessing central and peripheral HPA activity and affective measures. Blood samples have been collected at baseline and immediately post- and 1 hr following LP from 13 women with IBS and 13 controls. Plasma adrenocorticotropic hormone (ACTH), cortisol, epinephrine, and norepinephrine levels are analyzed. A single measure of cerebrospinal fluid (CSF) concentrations of corticotropin-releasing factor (CRFCSF) and norepinephrine CSF is noted. Affective assessments are used to rate anxiety and depression with the Hospital Anxiety and Depression Scale (HADS) and acute mood state is rated using the Stress Symptom Rating questionnaire (stress, anxiety, anger, arousal). The women with IBS display blunted ACTH and cortisol responses to the LP along with a profile of affective responsiveness suggestive of chronic psychosocial stress, although no CRF CSF differences between groups are observed.
Afifi, A.A., & Azin, M. ( 1972). Statistical analysis: A computer oriented approach. New York: Academic Press.
2.
Ahrens, T., Deuschle, M., Krumm, B., van der Pompe, G., den Boer, J.A., & Lederbogen, F. (2008). Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosomatic Medicine, 70(4), 461-467.
3.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., Rev.). Washington, DC: Author.
4.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author .
5.
Asmundson, G.J., Stein, M.B., & McCreary, D.R. (2002). Posttraumatic stress disorder symptoms influence health status of deployed peacekeepers and nondeployed military personnel. Journal of Nervous and Mental Disorders , 190(12), 807-815.
6.
Azzaro, A.J., Vandenberg, C.M., Blob, L.F., Kemper, E.M., Sharoky, M., Oren, D.A., et al. (2006). Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects. Journal of Clinical Pharmacology, 46(8), 933-944.
7.
Blanchard, E.B., Lackner, J.M., Jaccard, J., Rowell, D., Carosella, A.M., Powell, C., et al. (2008). The role of stress in symptom exacerbation among IBS patients. Journal of Psychosomatic Research, 64(2), 119-128.
8.
Böhmelt, A.H., Nater, U.M., Franke, S., Hellhammer, D.H., & Ehlert, U. ( 2005). Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosomatic Medicine, 67(2), 288-294.
9.
Carpenter, L.L., Tyrka, A.R., McDougle, C.J., Malison, R.T., Owens, M.J., Nemeroff, C.B., et al. (2004). Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology, 29(4), 777-784.
10.
Chang, L. ( 2006). Neuroendocrine and neuroimmune markers in IBS: Pathophysiological role or epiphenomenon? Gastroenterology, 130(2), 596-600.
11.
Chrousos, G.P. ( 1992). Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis: The corticotropin-releasing hormone perspective. Endocrinology and Metabolism Clinics of North America, 21(4), 833-858.
12.
Dickhaus, B., Mayer, E.A., Firooz, N., Stains, J., Conde, F., Olivas, T.I., et al. (2003). Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. American Journal of Gastroenterology, 98(1), 135-143.
13.
Drossman, D.A. ( 1999). The functional gastrointestinal disorders and the Rome II process. Gut, 45(Suppl. 2), 111-115.
14.
Ehlert, U., Nater, U.M., & Böhmelt, A. (2005). High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. Journal of Psychosomatic Research, 59(1), 7-10.
15.
Ellicott, A., Hammen, C., Gitlin, M., Brown, G., & Jamison, K. ( 1990). Life events and the course of bipolar disorder. American Journal of Psychiatry, 147(9), 1194-1198.
16.
Elsenbruch, S., Lucas, A., Holtmann, G., Haag, S., Gerken, G., Riemenschneider, N., et al. (2006). Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome . American Journal of Gastroenterology, 101(10), 2300-2307.
17.
Gabrys, J.B. ( 1982). Validity and reliability of the Eysenck Personality Inventory with outpatients. Psychology Report, 51(2), 541-542.
Gralnek, I.M., Hays, R.D., Kilbourne, A., Naliboff, B., & Mayer, E.A. ( 2000). The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology, 119(3), 654-660.
20.
Gwee, K.A., Leong, Y.L., Graham, C., McKendrick, M.W., Collins, S.M., Walters, S.J., et al. (1999). The role of psychological and biological factors in postinfective gut dysfunction. Gut, 44(3), 400-406.
21.
Hall, N.A., & Young, E.P. ( 1989). A high performance liquid chromatography method for the analysis of 35S-cystine: Application to the diagnosis of cystinosis. Clinica Chimica Acta, 184(1), 1-5.
22.
Heim, C., & Nemeroff, C.B. (1999). The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biological Psychiatry, 46(11), 1509-1522.
23.
Heitkemper, M.M., Jarrett, M., Cain, K., Shaver, J., Walker, E., & Lewis, L. ( 1995). Daily gastrointestinal symptoms in women with and without a diagnosis of IBS. Digestive Diseases and Sciences, 40(7), 1511-1519.
24.
King, S.L., & Hegadoren, K.M. (2002). Stress hormones: How do they measure up? Biological Research for Nursing, 4(2), 92-103.
25.
Lembo, T., FitzGerald, L., Matin, K., Woo, K., Mayer, E., & Naliboff, B. ( 1998). Audio and visual stimulation reduces patient discomfort during screening flexible sigmoidoscopy. American Journal of Gastroenterology, 93(7), 1113-1116.
26.
Lembo, T., Zaman, M., Jones, M., & Talley, N.J. ( 2007). Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: A twin study. Alimentary Pharmacology and Therapeutics, 25(11), 1343-1350.
27.
Mason, J.W., Wang, S., Yehuda, R., Riney, S., Charney, D.S., & Southwick, S.M. (2001). Psychogenic lowering of urinary cortisol levels linked to increased emotional numbing and a shame-depressive syndrome in combat-related posttraumatic stress disorder. Psychosomatic Medicine, 63(3), 387-401.
28.
Mayer, E.A., Naliboff, B.D., & Chang, L. ( 2002). Evolving pathophysiological model of functional gastrointestinal disorders: Implications for treatment. European Journal of Surgery, 587, 3-9.
29.
McEwen, B.S. ( 2006). Protective and damaging effects of stress mediators: Central role of the brain. Dialogues in Clinical Neuroscience , 8(4), 367-381.
30.
Munakata, J., Naliboffa, B., Harrafa, F., Kodnera, A., Lemboa, T., Changa, L., et al. (1997). Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology, 112(1), 55-63.
31.
Naliboff, B.D., Benton, D., Solomon, G.F., Morley, J.E., Fahey, J.L., Bloom, E.T., et al. (1991). Immunological changes in young and old adults during brief laboratory stress. Psychosomatic Medicine , 53(2), 121-132.
32.
Peeters, F., Nicholson, N.A., & Berkhof, J. ( 2003). Cortisol responses to daily events in major depressive disorder. Psychosomatic Medicine, 65(5), 836-841.
33.
Plotsky, P.M., Owens, M.J., & Nemeroff, C.B. (1998). Psychoneuroendocrinology of depression: Hypothalamic-pituitary-adrenal axis. Psychiatric Clinics of North America, 21(2), 293-307.
34.
Poland, R.E., & Rubin, R.T. ( 1982). Saliva cortisol levels following dexamethasone administration in endogenously depressed patients. Life Science, 30(2), 177-181.
35.
Posserud, I., Syrous, A., Lindström, L., Tack, J., Abrahamsson, H., & Simrén, M. (2007). Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology, 13(4), 1113-1123.
36.
Repetti, R.L., Taylor, S.E., & Seeman, T.E. ( 2002). Risky families: Family social environments and the mental and physical health of offspring. Psychological Bulletin, 128(2), 330-366.
37.
Sach, J., Bolus, R., FitzGerald, L., Naliboff, B., Chang, L., & Mayer, E. ( 2002). Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? American Journal of Gastroenterology , 97(12), 3131-3138.
38.
Spiller, R.C. ( 2007). Irritable bowel syndrome: Bacteria and inflammation-Clinical relevance now. Current Treatment Options in Gastroenterology , 10(4), 312-321.
39.
Spitzer, R.L., Williams, J.B., Gibbon, M., & First, M.B. ( 1992). The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Archives of General Psychiatry, 49(8), 624-629.
40.
Talley, N.J., Boyce, P.M., & Jones, M. ( 1998). Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut, 42(1), 47-53.
41.
Talley, N.J., Fett, S.L., & Zinsmeister, A.R. (1995). Self-reported abuse and gastrointestinal disease in outpatients: Association with irritable bowel-type symptoms. American Journal of Gastroenterology, 90(3), 366-371.
42.
Vythilingam, M., Anderson, G.M., Owens, M.J., Halaszynski, T.M., Bremner, J.D., Carpenter, L., et al. (2000). Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: Effects of yohimbine and naloxone. Journal of Clinical Endocrinology and Metabolism, 85(11), 4138-4145.
43.
Zigmond, A.S., & Snaith, R.P. ( 1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361-370.
